{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["acetylcholinesterase", "molecular docking", "molecular dynamic simulations", "neuroprotection", "zebrafish"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37765042", "DateRevised": {"Year": "2023", "Month": "10", "Day": "03"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "08", "Day": "31"}], "Language": ["eng"], "ELocationID": ["1234", "10.3390/ph16091234"], "Journal": {"ISSN": "1424-8247", "JournalIssue": {"Volume": "16", "Issue": "9", "PubDate": {"Year": "2023", "Month": "Aug", "Day": "31"}}, "Title": "Pharmaceuticals (Basel, Switzerland)", "ISOAbbreviation": "Pharmaceuticals (Basel)"}, "ArticleTitle": "Neuroprotective Properties of Oleanolic Acid-Computational-Driven Molecular Research Combined with In Vitro and In Vivo Experiments.", "Abstract": {"AbstractText": ["Oleanolic acid (OA), as a ubiquitous compound in the plant kingdom, is studied for both its neuroprotective and neurotoxic properties. The mechanism of acetylcholinesterase (AChE) inhibitory potential of OA is investigated using molecular dynamic simulations (MD) and docking as well as biomimetic tests. Moreover, the in vitro SH-SY5Y human neuroblastoma cells and the in vivo zebrafish model were used. The inhibitory potential towards the AChE enzyme is examined using the TLC-bioautography assay (the IC<sub>50</sub> value is 9.22 \u03bcM). The CH-\u03c0 interactions between the central fragment of the ligand molecule and the aromatic cluster created by the His440, Phe288, Phe290, Phe330, Phe331, Tyr121, Tyr334, Trp84, and Trp279 side chains are observed. The results of the in vitro tests using the SH-SY5Y cells indicate that the viability rate is reduced to 71.5%, 61%, and 43% at the concentrations of 100 \u00b5g/mL, 300 \u00b5g/mL, and 1000 \u00b5g/mL, respectively, after 48 h of incubation, whereas cytotoxicity against the tested cell line with the IC<sub>50</sub> value is 714.32 \u00b1 32.40 \u00b5g/mL. The in vivo tests on the zebrafish prove that there is no difference between the control and experimental groups regarding the mortality rate and morphology (<i>p</i> > 0.05)."]}, "AuthorList": [{"Identifier": ["0000-0002-9812-9114"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physical Chemistry, Institute of Chemical Sciences, Faculty of Chemistry, Maria Curie-Sklodowska University in Lublin, Pl. M. Curie-Sk\u0142odowskiej 3, 20-031 Lublin, Poland."}, {"Identifier": [], "Affiliation": "Department of Pharmacognosy with Medicinal Plants Garden, Medical University of Lublin, ul. Chodzki 1, 20-093 Lublin, Poland."}], "LastName": "St\u0119pnik", "ForeName": "Katarzyna", "Initials": "K"}, {"Identifier": ["0000-0001-7076-600X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy with Medicinal Plants Garden, Medical University of Lublin, ul. Chodzki 1, 20-093 Lublin, Poland."}], "LastName": "Kukula-Koch", "ForeName": "Wirginia", "Initials": "W"}, {"Identifier": ["0000-0003-1427-8188"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biopharmacy, Medical University of Lublin, ul. Chodzki 4a, 20-093 Lublin, Poland."}, {"Identifier": [], "Affiliation": "Jerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences, ul. Niezapominajek 8, 30-239 Krak\u00f3w, Poland."}], "LastName": "Plazinski", "ForeName": "Wojciech", "Initials": "W"}, {"Identifier": ["0000-0003-3768-3514"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Photobiology and Molecular Diagnostics, Intercollegiate Faculty of Biotechnology, University of Gdansk and Medical University of Gdansk, ul. Abrahama 58, 80-307 Gda\u0144sk, Poland."}], "LastName": "Rybicka", "ForeName": "Magda", "Initials": "M"}, {"Identifier": ["0000-0001-8857-847X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Experimental and Clinical Pharmacology, Medical University of Lublin, ul. Jaczewskiego Str. 8b, 20-090 Lublin, Poland."}], "LastName": "Gawel", "ForeName": "Kinga", "Initials": "K"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Pharmaceuticals (Basel)", "NlmUniqueID": "101238453", "ISSNLinking": "1424-8247"}, "CoiStatement": "The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Tarabasz D., Szczeblewski P., Laskowski T., P\u0142azi\u0144ski W., Baranowska-W\u00f3jcik E., Szwajgier D., Kukula-Koch W., Meissner H.O. The Distribution of Glucosinolates in Different Phenotypes of Lepidium peruvianum and Their Role as Acetyl- and Butyrylcholinesterase Inhibitors\u2014In Silico and In Vitro Studies. Int. J. Mol. Sci. 2022;23:4858. doi: 10.3390/ijms23094858.", "ArticleIdList": ["10.3390/ijms23094858", "PMC9101689", "35563248"]}, {"Citation": "Kukula-Koch W., Koch W., Czernicka L., G\u0142owniak K., Asakawa Y., Umeyama A., Marzec Z., Kuzuhara T. MAO-A Inhibitory Potential of Terpene Constituents from Ginger Rhizomes-A Bioactivity Guided Fractionation. Molecules. 2018;23:1301. doi: 10.3390/molecules23061301.", "ArticleIdList": ["10.3390/molecules23061301", "PMC6099963", "29844252"]}, {"Citation": "Urbain A., Sim\u00f5es-Pires C.A. Thin-Layer Chromatography for the Detection and Analysis of Bioactive Natural Products. In: Meyers R.A., editor. Encyclopedia of Analytical Chemistry. Wiley; Hoboken, NJ, USA: 2023.", "ArticleIdList": ["10.1002/9780470027318.a9907.pub2"]}, {"Citation": "Rajmohan R., Reddy P.H. Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer\u2019s disease Neurons. J. Alzheimer\u2019s Dis. JAD. 2017;57:975\u2013999. doi: 10.3233/JAD-160612.", "ArticleIdList": ["10.3233/JAD-160612", "PMC5793225", "27567878"]}, {"Citation": "Abdykerimova S., Sakipova Z., Nakonieczna S., Koch W., Biernasiuk A., Grabarska A., Malm A., Kozhanova K., Kukula-Koch W. Superior Antioxidant Capacity of Berberis iliensis-HPLC-Q-TOF-MS Based Phytochemical Studies and Spectrophotometric Determinations. Antioxidants. 2020;9:504. doi: 10.3390/antiox9060504.", "ArticleIdList": ["10.3390/antiox9060504", "PMC7346193", "32526940"]}, {"Citation": "Smyrska-Wieleba N., Mroczek T. Natural Inhibitors of Cholinesterases: Chemistry, Structure\u2013Activity and Methods of Their Analysis. Int. J. Mol. Sci. 2023;24:2722. doi: 10.3390/ijms24032722.", "ArticleIdList": ["10.3390/ijms24032722", "PMC9916849", "36769043"]}, {"Citation": "Mroczek T., Dymek A., Widelski J., Wojtanowski K.K. The Bioassay-Guided Fractionation and Identification of Potent Acetylcholinesterase Inhibitors from Narcissus c.v. \u2019Hawera\u2019 Using Optimized Vacuum Liquid Chromatography, High Resolution Mass Spectrometry and Bioautography. Metabolites. 2020;10:395. doi: 10.3390/metabo10100395.", "ArticleIdList": ["10.3390/metabo10100395", "PMC7599570", "33020380"]}, {"Citation": "Ouyang C., Ma X., Zhao J., Li S., Liu C., Tang Y., Zhou J., Chen J., Li X., Li W. Oleanolic acid inhibits mercury chloride induced-liver ferroptosis by regulating ROS/iron overload. Ecotoxicol. Environ. Saf. 2023;258:114973. doi: 10.1016/j.ecoenv.2023.114973.", "ArticleIdList": ["10.1016/j.ecoenv.2023.114973", "37163906"]}, {"Citation": "Ayeleso T.B., Matumba M.G., Mukwevho E. Oleanolic Acid and Its Derivatives: Biological Activities and Therapeutic Potential in Chronic Diseases. Molecules. 2017;22:1915. doi: 10.3390/molecules22111915.", "ArticleIdList": ["10.3390/molecules22111915", "PMC6150249", "29137205"]}, {"Citation": "Castellano J.M., Ramos-Romero S., Perona J.S. Oleanolic Acid: Extraction, Characterization and Biological Activity. Nutrients. 2022;14:623. doi: 10.3390/nu14030623.", "ArticleIdList": ["10.3390/nu14030623", "PMC8838233", "35276982"]}, {"Citation": "Lu C., Zhang C., Zhao F., Li D., Lu W. Biosynthesis of ursolic acid and oleanolic acid in Saccharomyces cerevisiae. AIChE J. 2018;64:3794\u20133802. doi: 10.1002/aic.16370.", "ArticleIdList": ["10.1002/aic.16370"]}, {"Citation": "Soczewi\u0144ski E., Wachtmeister C.A. The relation between the composition of certain ternary two-phase solvent systems and RM values. J. Chromatogr. 1962;7:311\u2013320. doi: 10.1016/S0021-9673(01)86422-0.", "ArticleIdList": ["10.1016/S0021-9673(01)86422-0"]}, {"Citation": "Janicka M., Sztanke M., Sztanke K. Predicting the Blood-Brain Barrier Permeability of New Drug-like Compounds via HPLC with Various Stationary Phases. Molecules. 2020;25:487. doi: 10.3390/molecules25030487.", "ArticleIdList": ["10.3390/molecules25030487", "PMC7037052", "31979316"]}, {"Citation": "St\u0119pnik K. Biomimetic Chromatographic Studies Combined with the Computational Approach to Investigate the Ability of Triterpenoid Saponins of Plant Origin to Cross the Blood\u2013Brain Barrier. Int. J. Mol. Sci. 2021;22:3573. doi: 10.3390/ijms22073573.", "ArticleIdList": ["10.3390/ijms22073573", "PMC8037809", "33808219"]}, {"Citation": "Platzer G., Mayer M., Beier A., Br\u00fcschweiler S., Fuchs J.E., Engelhardt H., Geist L., Bader G., Sch\u00f6rghuber J., Lichtenecker R., et al. PI by NMR: Probing CH\u2013\u03c0 Interactions in Protein\u2013Ligand Complexes by NMR Spectroscopy. Angew. Chem. Int. Ed. 2020;59:14861. doi: 10.1002/anie.202003732.", "ArticleIdList": ["10.1002/anie.202003732", "PMC7496880", "32421895"]}, {"Citation": "Ferreira de Freitas R., Schapira M. A systematic analysis of atomic protein\u2013ligand interactions in the PDB. Med. Chem.Commun. 2017;8:1970\u20131981. doi: 10.1039/C7MD00381A.", "ArticleIdList": ["10.1039/C7MD00381A", "PMC5708362", "29308120"]}, {"Citation": "Nishio M., Umezawa Y., Fantini J., Weiss M.S., Chakrabarti P. CH\u2013\u03c0 hydrogen bonds in biological macromolecules. Phys.Chem. Chem. Phys. 2014;16:12648\u201312683. doi: 10.1039/C4CP00099D.", "ArticleIdList": ["10.1039/C4CP00099D", "24836323"]}, {"Citation": "World Health Organization . Global Action Plan on the Public Health Response to Dementia 2017\u20132025. WHO; Geneva, Switzerland: 2017."}, {"Citation": "Birks J., Grimley E.J. Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst. Rev. 2009;21:CD003120. doi: 10.1002/14651858.CD003120.pub3.", "ArticleIdList": ["10.1002/14651858.CD003120.pub3", "19160216"]}, {"Citation": "Joo S.S., Lee D.I. Potential effects of microglial activation induced by ginsenoside Rg3 in rat primary culture: Enhancement of type a macrophage scavenger receptor expression. Arch. Pharm. Res. 2005;28:1164\u20131169. doi: 10.1007/BF02972981.", "ArticleIdList": ["10.1007/BF02972981", "16276974"]}, {"Citation": "Chen F., Eckman E.A., Eckman C.B. Reductions in levels of the Alzheimer\u2019s amyloid \u03b2 peptide after oral administration of ginsenosides. FASEB J. 2006;20:1269\u20131271. doi: 10.1096/fj.05-5530fje.", "ArticleIdList": ["10.1096/fj.05-5530fje", "16636099"]}, {"Citation": "Li N., Liu B., Dluzen D.E., Jin Y. Protective effects of ginsenoside Rg2 against glutamate induced neurotoxicity in PC12 cells. J. Ethnopharmacol. 2007;111:458\u2013463. doi: 10.1016/j.jep.2006.12.015.", "ArticleIdList": ["10.1016/j.jep.2006.12.015", "17257792"]}, {"Citation": "Joo S.S., Yoo Y.M., Ahn B.W., Nam S.Y., Kim Y.-B., Hwang K.W., Lee D.I. Prevention of inflammation-mediated neurotoxicity by Rg3 and its role in microglial activation. Biol. Pharm. Bull. 2008;31:1392\u20131396. doi: 10.1248/bpb.31.1392.", "ArticleIdList": ["10.1248/bpb.31.1392", "18591781"]}, {"Citation": "Shieh P.C., Tsao C.W., Li J.S., Wu H.T., Wen Y.J., Kou D.H., Cheng J.T. Role of pituitary adenylate cyclase-activating polypeptide (PACAP) in the action of ginsenoside Rh2 against betaamyloid-induced inhibition of rat brain astrocytes. Neurosci. Lett. 2008;434:1\u20135. doi: 10.1016/j.neulet.2007.12.032.", "ArticleIdList": ["10.1016/j.neulet.2007.12.032", "18313848"]}, {"Citation": "Wakabayashi I., Yasui K. Wogonin inhibits inducible prostaglandin E2 production in macrophages. Eur. J. Pharmacol. 2000;406:477\u2013481. doi: 10.1016/S0014-2999(00)00695-6.", "ArticleIdList": ["10.1016/S0014-2999(00)00695-6", "11040356"]}, {"Citation": "Park B.K., Heo M.Y., Par H., Kim H.P. Inhibition of TPA-induced cyclooxygenase-2 expression and skin inflammation in mice by wogonin, a plant flavone from Scutellaria radix. Eur. J. Pharmacol. 2001;425:153\u2013157. doi: 10.1016/S0014-2999(01)01187-6.", "ArticleIdList": ["10.1016/S0014-2999(01)01187-6", "11502282"]}, {"Citation": "Nakamura N., Hayasaka S., Zhang X.Y., Nagaki Y., Matsumoto M., Hayasaka Y., Terasawa K. Effects of baicalein, baicalin, and wogonin on interleukin-6 and interleukin-8 expression, and nuclear factor-kb binding activities induced by interleukin-1beta in human retinal pigment epithelial cell line. Exp. Eye Res. 2003;77:195\u2013202. doi: 10.1016/S0014-4835(03)00116-7.", "ArticleIdList": ["10.1016/S0014-4835(03)00116-7", "12873450"]}, {"Citation": "Suk K., Lee H., Kang S.S., Cho G.J., Choi W.S. Flavonoid baicalein attenuates activation induced cell death of brain microglia. J. Pharmacol. Exp. Ther. 2003;305:638\u2013645. doi: 10.1124/jpet.102.047373.", "ArticleIdList": ["10.1124/jpet.102.047373", "12606597"]}, {"Citation": "Hosseinzadeh H., Ramezani M., Shafaei H., Taghiabadi E. Anticonvulsant effect of Berberis integerrima L. root extracts in mice. J. Acupunct. Meridian Stud. 2013;6:12\u201317. doi: 10.1016/j.jams.2012.07.018.", "ArticleIdList": ["10.1016/j.jams.2012.07.018", "23433050"]}, {"Citation": "Ya\u2019u J., Yaro A.H., Malami S., Musa M.A., Abubakar A., Yahaya S.M., Chindo B.A., Anuka J.A., Hussaini I.M. Anticonvulsant activity of aqueous fraction of Carissa edulis root bark. Pharm. Biol. 2015;53:1329\u20131338. doi: 10.3109/13880209.2014.981280.", "ArticleIdList": ["10.3109/13880209.2014.981280", "25856720"]}, {"Citation": "Bhat J.U., Nizami Q., Asiaf A., Parray S.A., Ahmad S.T., Aslam M., Khanam R., Mujeeb M., Umar S., Siddiqi A. Anticonvulsant activity of methanolic and aqueous extracts of Melissa parviflora in experimentally induced Swiss albino mice. EXCLI J. 2012;11:1\u20136.", "ArticleIdList": ["PMC4897659", "27298604"]}, {"Citation": "Tariq U., Butt M.S., Pasha I., Faisal M.N. Neuroprotective effects of Olea europaea L. fruit extract against cigarette smoke-induced depressive-like behaviors in Sprague-Dawley rats. J. Food Biochem. 2021;45:e14014. doi: 10.1111/jfbc.14014.", "ArticleIdList": ["10.1111/jfbc.14014", "34796529"]}, {"Citation": "Angeloni C., Malaguti M., Barbalace M.C., Hrelia S. Bioactivity of Olive Oil Phenols in Neuroprotection. Int. J. Mol. Sci. 2017;18:2230. doi: 10.3390/ijms18112230.", "ArticleIdList": ["10.3390/ijms18112230", "PMC5713200", "29068387"]}, {"Citation": "dos Santos-Neto L.L., Toledo M.A.d.V., Medeiros-Souza P., de Souza G.A. The use of herbal medicine in Alzheimer\u2019s disease\u2014A systematic review. Evid. Based Complement. Altern. Med. 2006;3:441\u2013445. doi: 10.1093/ecam/nel071.", "ArticleIdList": ["10.1093/ecam/nel071", "PMC1697739", "17173107"]}, {"Citation": "Bozin B., Mika-Dukic N., Samojlik I., Jovin E. Antimicrobial and antioxidant properties of rosemary and sage (Rosmarinus officinalis L. and Salvia officinalis L., Lamiaceae) essential oils. J. Agric. Food. Chem. 2007;55:7879\u20137885. doi: 10.1021/jf0715323.", "ArticleIdList": ["10.1021/jf0715323", "17708648"]}, {"Citation": "Imanshahidi M., Hosseinzadeh H. The pharmacological effects of Salvia species on the central nervous system. Phytother. Res. 2006;20:427\u2013437. doi: 10.1002/ptr.1898.", "ArticleIdList": ["10.1002/ptr.1898", "16619340"]}, {"Citation": "Visioli F., Grande S., Bogani P., Galli C. The role of antioxidant in the Mediterranean diets: Focus on cancer. Eur. J. Cancer Prev. 2004;13:337\u2013343. doi: 10.1097/01.cej.0000137513.71845.f6.", "ArticleIdList": ["10.1097/01.cej.0000137513.71845.f6", "15554562"]}, {"Citation": "Ninfali P., Mea G., Giorgini S., Rocchi M., Bacchiocca M. Antioxidant capacity of vegetables, spices, and dressings relevant to nutrition. Br. J. Nutr. 2005;93:257\u2013266. doi: 10.1079/BJN20041327.", "ArticleIdList": ["10.1079/BJN20041327", "15788119"]}, {"Citation": "Cheung S., Tai J. Anti-proliferative and antioxidant properties of rosemary Rosmarinus officinalis. Oncol. Rep. 2007;17:1525\u20131531. doi: 10.3892/or.17.6.1525.", "ArticleIdList": ["10.3892/or.17.6.1525", "17487414"]}, {"Citation": "Lin S.X., Curtis M.A., Sperry J. Pyridine alkaloids with activity in the central nervous system. Bioorg. Med. Chem. 2020;28:115820. doi: 10.1016/j.bmc.2020.115820.", "ArticleIdList": ["10.1016/j.bmc.2020.115820", "PMC7561606", "33120080"]}, {"Citation": "Arens H., Borbe H.O., Ulbrich B., St\u00f6ckigt J. Detection of pericine, a new CNS-active indole alkaloid from Picralima nitida cell suspension culture by opiate receptor binding studies. Planta Med. 1982;46:210\u2013214. doi: 10.1055/s-2007-971216.", "ArticleIdList": ["10.1055/s-2007-971216", "6298847"]}, {"Citation": "Paladini A.C., Marder M., Viola H., Wolfman C., Wasowski C., Medina J.H. Flavonoids and the central nervous system: From forgotten factors to potent anxiolytic compounds. J. Pharm. Pharmacol. 1999;51:519\u2013526. doi: 10.1211/0022357991772790.", "ArticleIdList": ["10.1211/0022357991772790", "10411210"]}, {"Citation": "J\u00e4ger A.K., Saaby L. Flavonoids and the CNS. Molecules. 2011;16:1471\u20131485. doi: 10.3390/molecules16021471.", "ArticleIdList": ["10.3390/molecules16021471", "PMC6259921", "21311414"]}, {"Citation": "Sun A., Xu X., Lin J., Cui X., Xu R. Neuroprotection by Saponins. Phytother. Res. 2015;29:187\u2013200. doi: 10.1002/ptr.5246.", "ArticleIdList": ["10.1002/ptr.5246", "25408503"]}, {"Citation": "Yuan C.S., Wang C.Z., Wicks S.M., Qi L.W. Chemical and pharmacological studies of saponins with a focus on American ginseng. J. Gins. Res. 2010;34:160\u2013167. doi: 10.5142/jgr.2010.34.3.160.", "ArticleIdList": ["10.5142/jgr.2010.34.3.160", "PMC3043615", "21359120"]}, {"Citation": "Hussain G., Huang J., Rasul A., Anwar H., Imran A., Maqbool J., Razzaq A., Aziz N., Makhdoom E.U.H., Konuk M., et al. Putative Roles of Plant-Derived Tannins in Neurodegenerative and Neuropsychiatry Disorders: An Updated Review. Molecules. 2019;24:2213. doi: 10.3390/molecules24122213.", "ArticleIdList": ["10.3390/molecules24122213", "PMC6630756", "31200495"]}, {"Citation": "Takahashi R.N., de Lima T.C., Morato G.S. Pharmacological actions of tannic acid; II. Evaluation of CNS activity in animals. Planta Med. 1986;52:272\u2013275. doi: 10.1055/s-2007-969150.", "ArticleIdList": ["10.1055/s-2007-969150", "3763716"]}, {"Citation": "Awasthi M., Upadhyay A.K., Singh S., Pandey V.P., Dwivedi U.N. Terpenoids as promising therapeutic molecules against Alzheimer\u2019s disease: Amyloid beta- and acetylcholinesterase-directed pharmacokinetic and molecular docking analyses. Mol. Simul. 2018;44:1\u201311. doi: 10.1080/08927022.2017.1334880.", "ArticleIdList": ["10.1080/08927022.2017.1334880"]}, {"Citation": "Min S.L., Liew S.Y., Chear N.J.Y., Goh B.H., Tan W.N., Khaw K.Y. Plant Terpenoids as the Promising Source of Cholinesterase Inhibitors for Anti-AD Therapy. Biology. 2022;11:307. doi: 10.3390/biology11020307.", "ArticleIdList": ["10.3390/biology11020307", "PMC8869317", "35205173"]}, {"Citation": "Mony T.J., Elahi F., Choi J.W., Park S.J. Neuropharmacological Effects of Terpenoids on Preclinical Animal Models of Psychiatric Disorders: A Review. Antioxidants. 2022;11:1834. doi: 10.3390/antiox11091834.", "ArticleIdList": ["10.3390/antiox11091834", "PMC9495487", "36139909"]}, {"Citation": "Meckes M., Calzada F., Tortoriello J., Gonz\u00e1lez J.L., Mart\u00ednez M. Terpenoids Isolated from Psidium guajava Hexane Extract with Depressant Activity on Central Nervous System. Phytother. Res. 1996;10:600\u2013603. doi: 10.1002/(SICI)1099-1573(199611)10:7<600::AID-PTR918>3.0.CO;2-7.", "ArticleIdList": ["10.1002/(SICI)1099-1573(199611)10:7<600::AID-PTR918>3.0.CO;2-7"]}, {"Citation": "Mohanty I.R., Borde M., Kumar S., Maheshwari U. Dipeptidyl peptidase IV Inhibitory activity of Terminalia arjuna attributes to its cardioprotective effects in experimental diabetes: In silico, in vitro and in vivo analyses. Phytomedicine. 2019;57:158\u2013165. doi: 10.1016/j.phymed.2018.09.195.", "ArticleIdList": ["10.1016/j.phymed.2018.09.195", "30668318"]}, {"Citation": "Pawar R.S., Bhutani K.K. Effect of oleanane triterpenoids from Terminalia arjuna\u2014A cardioprotective drug on the process of respiratory oxyburst. Phytomedicine. 2005;12:391\u2013393. doi: 10.1016/j.phymed.2003.11.007.", "ArticleIdList": ["10.1016/j.phymed.2003.11.007", "15957375"]}, {"Citation": "Kapoor D., Vijayvergiya R., Dhawan V. Terminalia arjuna in coronary artery disease: Ethnopharmacology, pre-clinical, clinical & safety evaluation. J. Ethnopharmacol. 2014;155:1029\u20131045.", "ArticleIdList": ["25014508"]}, {"Citation": "Sudharsan P.T., Mythili Y., Selvakumar E., Varalakshmi P. Cardioprotective effect of pentacyclic triterpene, lupeol and its ester on cyclophosphamide-induced oxidative stress. Hum. Exp. Toxicol. 2005;24:313\u2013318. doi: 10.1191/0960327105ht530oa.", "ArticleIdList": ["10.1191/0960327105ht530oa", "16004198"]}, {"Citation": "Pugazhendhi A., Shafreen R.B., Devi K.P., Suganthy N. Assessment of antioxidant, anticholinesterase and antiamyloidogenic effect of Terminalia chebula, Terminalia arjuna and its bioactive constituent 7-Methyl gallic acid\u2014An in vitro and in silico studies. J. Mol. Liq. 2018;257:69\u201381. doi: 10.1016/j.molliq.2018.02.081.", "ArticleIdList": ["10.1016/j.molliq.2018.02.081"]}, {"Citation": "Gupta D., Kumar M. Evaluation of in vitro antimicrobial potential and GC-MS analysis of Camellia sinensis and Terminalia arjuna. Biotechnol. Rep. 2017;13:19\u201325. doi: 10.1016/j.btre.2016.11.002.", "ArticleIdList": ["10.1016/j.btre.2016.11.002", "PMC5361076", "28352558"]}, {"Citation": "Mandal S., Patra A., Samanta A., Roy S., Mandal A., Das Mahapatra T., Pradhan S., Das K., Nandi D.K. Analysis of phytochemical profile of Terminalia arjuna bark extract with antioxidative and antimicrobial properties. Asian Pac. J. Trop. Biomed. 2013;3:960\u2013966. doi: 10.1016/S2221-1691(13)60186-0.", "ArticleIdList": ["10.1016/S2221-1691(13)60186-0", "PMC3805097", "24093787"]}, {"Citation": "Dube N., Nimgulkar C., Bharatraj D.K. Validation of therapeutic anti-inflammatory potential of Arjuna KsheeraPaka\u2014A traditional Ayurvedic formulation of Terminalia arjuna. J. Tradit. Complement. Med. 2017;7:414\u2013420. doi: 10.1016/j.jtcme.2016.11.006.", "ArticleIdList": ["10.1016/j.jtcme.2016.11.006", "PMC5634724", "29034188"]}, {"Citation": "Ahmad M.S., Ahmad S., Gautam B., Arshad M., Afzal M. Terminalia arjuna, a herbal remedy against environmental carcinogenicity: An in vitro and in vivo study. Egypt. J. Medical Hum. Genet. 2014;15:61\u201367. doi: 10.1016/j.ejmhg.2013.10.004.", "ArticleIdList": ["10.1016/j.ejmhg.2013.10.004"]}, {"Citation": "Ruszkowski P., Bobkiewicz-Kozlowska T. Natural Triterpenoids and their Derivatives with Pharmacological Activity Against Neurodegenerative Disorders. Mini-Rev. Org. Chem. 2014;11:307\u2013315. doi: 10.2174/1570193X1103140915111559.", "ArticleIdList": ["10.2174/1570193X1103140915111559"]}, {"Citation": "Bhattacharjee B., Pal P.K., Ghosh A.K., Mishra S., Chattopadhyay A., Bandyopadhyay D. Aqueous bark extract of Terminalia arjuna protects against cadmium-induced hepatic and cardiac injuries in male Wistar rats through antioxidative mechanisms. Food Chem. Toxicol. 2019;124:249\u2013264. doi: 10.1016/j.fct.2018.12.008.", "ArticleIdList": ["10.1016/j.fct.2018.12.008", "30529122"]}, {"Citation": "Tanaka H., Mizojiri K. Drug-protein binding and blood-brain barrier permeability. J. Pharmacol. Exp. Ther. 1999;288:912\u2013918.", "ArticleIdList": ["10027826"]}, {"Citation": "Platts J.A., Abraham M.H., Zhao Y.H., Hersey A., Ijaz L., Butina D. Correlation and prediction of a large blood-brain distribution data set--an LFER study. Eur. J. Med. Chem. 2001;36:719\u2013730. doi: 10.1016/S0223-5234(01)01269-7.", "ArticleIdList": ["10.1016/S0223-5234(01)01269-7", "11672881"]}, {"Citation": "Sapkota A., Choi J.W. Oleanolic Acid Provides Neuroprotection against Ischemic Stroke through the Inhibition of Microglial Activation and NLRP3 Inflammasome Activation. Biomol. Ther. 2022;30:55\u201363. doi: 10.4062/biomolther.2021.154.", "ArticleIdList": ["10.4062/biomolther.2021.154", "PMC8724842", "34873072"]}, {"Citation": "Chen C., Ai Q., Shi A., Wang N., Wang L., Wei Y. Oleanolic acid and ursolic acid: Therapeutic potential in neurodegenerative diseases, neuropsychiatric diseases and other brain disorders. Nutr. Neurosci. 2023;26:414\u2013428. doi: 10.1080/1028415X.2022.2051957.", "ArticleIdList": ["10.1080/1028415X.2022.2051957", "35311613"]}, {"Citation": "Gudoityte E., Arandarcikaite O., Mazeikiene I., Bendokas V., Liobikas J. Ursolic and Oleanolic Acids: Plant Metabolites with Neuroprotective Potential. Int. J. Mol. Sci. 2021;22:4599. doi: 10.3390/ijms22094599.", "ArticleIdList": ["10.3390/ijms22094599", "PMC8124962", "33925641"]}, {"Citation": "Fantini S., Sassaroli A., Tga\u2019valekos K.T., Kornbluth J. Cerebral blood flow and autoregulation: Current measurement techniques and prospects for noninvasive optical methods. Neurophotonics. 2016;3:031411. doi: 10.1117/1.NPh.3.3.031411.", "ArticleIdList": ["10.1117/1.NPh.3.3.031411", "PMC4914489", "27403447"]}, {"Citation": "Liu X., Smith B.J., Chen C., Callegari E., Becker S.L., Chen X., Cianfrogna J., Doran A.C., Doran S.D., Gibbs J.P., et al. Use of a Physiologically Based Pharmacokinetic Model to Study the Time to Reach Brain Equilibrium: An Experimental Analysis of the Role of Blood-Brain Barrier Permeability, Plasma Protein Binding, and Brain Tissue Binding. J. Pharmacol. Exp. Ther. 2005;313:1254\u20131262. doi: 10.1124/jpet.104.079319.", "ArticleIdList": ["10.1124/jpet.104.079319", "15743928"]}, {"Citation": "Talevi A., Bellera C.L. The ADME Encyclopedia. Springer; Cham, Switzerland: 2022. Free Drug Theory.", "ArticleIdList": ["10.1007/978-3-030-51519-5_51-2"]}, {"Citation": "Hammarlund-Udenaes M., Frid\u00e9n M., Syv\u00e4nen S., Gupta A. On the rate and extent of drug delivery to the brain. Pharm. Res. 2008;25:1737\u20131750. doi: 10.1007/s11095-007-9502-2.", "ArticleIdList": ["10.1007/s11095-007-9502-2", "PMC2469271", "18058202"]}, {"Citation": "Kalvass J.C., Maurer T.S., Pollack G.M. Use of plasma and brain unbound fractions to assess the extent of brain distribution of 34 drugs: Comparison of unbound concentration ratios to in vivo p-glycoprotein efflux ratios. Drug Metab. Dispos. 2007;35:660\u2013666. doi: 10.1124/dmd.106.012294.", "ArticleIdList": ["10.1124/dmd.106.012294", "17237155"]}, {"Citation": "Banks W.A., Kastin A.J. Peptides and the blood-brain barrier: Lipophilicity as a predictor of permeability. Brain Res. Bull. 1985;15:287\u2013292. doi: 10.1016/0361-9230(85)90153-4.", "ArticleIdList": ["10.1016/0361-9230(85)90153-4", "2413968"]}, {"Citation": "Chikhale E.G., Ng K.-Y., Burton P.S., Borchardt R.T. Hydrogen bonding potential as a determinant of the in vitro and in situ blood-brain barrier permeability of peptides. Pharm. Res. 1994;11:412\u2013419. doi: 10.1023/A:1018969222130.", "ArticleIdList": ["10.1023/A:1018969222130", "8008709"]}, {"Citation": "Abbott N.J. Prediction of blood\u2013brain barrier permeation in drug discovery from in vivo, in vitro and in silico models. Drug Discov. Today Technol. 2004;1:407\u2013416. doi: 10.1016/j.ddtec.2004.11.014.", "ArticleIdList": ["10.1016/j.ddtec.2004.11.014", "24981621"]}, {"Citation": "Clark D.E. In silico prediction of blood\u2013brain barrier permeation. Drug Discov. Today. 2003;8:927\u2013933. doi: 10.1016/S1359-6446(03)02827-7.", "ArticleIdList": ["10.1016/S1359-6446(03)02827-7", "14554156"]}, {"Citation": "St\u00e9en E.J.L., Vugts D.J., Windhorst A.D. The Application of in silico Methods for Prediction of Blood-Brain Barrier Permeability of Small Molecule PET Tracers. Front. Nucl. Med. 2022;2:853475. doi: 10.3389/fnume.2022.853475.", "ArticleIdList": ["10.3389/fnume.2022.853475"]}, {"Citation": "Radan M., Djikic T., Obradovic D., Nikolic K. Application of in vitro PAMPA technique and in silico computational methods for blood-brain barrier permeability prediction of novel CNS drug candidates. Eur. J. Pharms. Sci. 2022;168:106056. doi: 10.1016/j.ejps.2021.106056.", "ArticleIdList": ["10.1016/j.ejps.2021.106056", "34740787"]}, {"Citation": "Yang R., Wei T., Goldberg H., Wang W., Cullion K., Kohane D.S. Getting Drugs Across Biological Barriers. Adv. Mater. 2017;29:1606596. doi: 10.1002/adma.201606596.", "ArticleIdList": ["10.1002/adma.201606596", "PMC5683089", "28752600"]}, {"Citation": "Oldendorf W.H. Lipid solubility and drug penetration of the blood brain barrier. Proc. Soc. Exp. Biol. Med. 1974;147:813\u2013815. doi: 10.3181/00379727-147-38444.", "ArticleIdList": ["10.3181/00379727-147-38444", "4445171"]}, {"Citation": "Aryal M., Arvanitis C.D., Alexander P.M., McDannold N. Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system. Adv. Drug Deliv. Rev. 2014;72:94\u2013109. doi: 10.1016/j.addr.2014.01.008.", "ArticleIdList": ["10.1016/j.addr.2014.01.008", "PMC4041837", "24462453"]}, {"Citation": "Feher M., Sourial E., Schmidt J.M. A simple model for the prediction of blood-brain partitioning. Int J. Pharm. 2000;201:239\u2013247. doi: 10.1016/S0378-5173(00)00422-1.", "ArticleIdList": ["10.1016/S0378-5173(00)00422-1", "10878329"]}, {"Citation": "Liu R., Sun H., So S.-S. Development of quantitative structure \u2212 property relationship models for early ADME evaluation in drug discovery. 2. Blood-brain barrier penetration. J. Chem. Inf. Comput. Sci. 2001;41:1623\u20131632. doi: 10.1021/ci010290i.", "ArticleIdList": ["10.1021/ci010290i", "11749589"]}, {"Citation": "Prasanna S., Doerksen R.J. Topological polar surface area: A useful descriptor in 2D-QSAR. Curr. Med. Chem. 2009;16:21\u201341. doi: 10.2174/092986709787002817.", "ArticleIdList": ["10.2174/092986709787002817", "PMC7549127", "19149561"]}, {"Citation": "Van de Waterbeemd H. In silico models to predict oral absorption. In: Taylor J.B., Triggle D.J., editors. Comprehensive Medicinal Chemistry II. Elsevier; Amsterdam, The Netherlands: 2007. pp. 669\u2013697."}, {"Citation": "Barbato F. The Use of Immobilised Artificial Membrane (IAM) Chromatography for Determination of Lipophilicity. Curr. Comput. Drug Des. 2006;2:341\u2013352. doi: 10.2174/157340906778992319.", "ArticleIdList": ["10.2174/157340906778992319"]}, {"Citation": "Ogden P.B., Coym J.W. Retention mechanism of a cholesterol-coated C18 stationary phase: Van\u2019t Hoff and Linear Solvation Energy Relationships (LSER) approaches. J. Chromatogr. A. 2011;1218:2936\u20132943. doi: 10.1016/j.chroma.2011.03.018.", "ArticleIdList": ["10.1016/j.chroma.2011.03.018", "21457990"]}, {"Citation": "Stavrakov G., Philipova I., Lukarski A., Atanasova M., Zheleva D., Zhivkova Z.D., Ivanov S., Atanasova T., Konstantinov S., Doytchinova I. Galantamine-curcumin hybrids as dual-site binding acetylcholinesterase inhibitors. Molecules. 2020;25:3341. doi: 10.3390/molecules25153341.", "ArticleIdList": ["10.3390/molecules25153341", "PMC7435983", "32717861"]}, {"Citation": "St\u0119pnik K., Kukula-Koch W., Plazinski W., Gawel K., Gawe\u0142-B\u0119ben K., Khurelbat D., Boguszewska-Czubara A. Significance of Astragaloside IV from the Roots of Astragalus mongholicus as an Acetylcholinesterase Inhibitor\u2014From the Computational and Biomimetic Analyses to the In Vitro and In Vivo Studies of Safety. Int. J. Mol. Sci. 2023;24:9152. doi: 10.3390/ijms24119152.", "ArticleIdList": ["10.3390/ijms24119152", "PMC10252989", "37298103"]}, {"Citation": "Mente S., Lombardo F. A recursive-partitioning model for blood\u2013brain barrier permeation. J. Comput. Aided Mol. Des. 2005;19:465\u2013481. doi: 10.1007/s10822-005-9001-7.", "ArticleIdList": ["10.1007/s10822-005-9001-7", "16331406"]}, {"Citation": "Kukula-Koch W., Mroczek T. Application of hydrostatic CCC-TLC-HPLC-ESI-TOF-MS for the bioguided fractionation of anticholinesterase alkaloids from Argemonemexicana L. roots. Anal. Bioanal. Chem. 2015;407:2581\u20132589. doi: 10.1007/s00216-015-8468-x.", "ArticleIdList": ["10.1007/s00216-015-8468-x", "PMC4365284", "25618762"]}, {"Citation": " [(accessed on 10 June 2023)]; Available online:  https://cactus.nci.nih.gov/translate."}, {"Citation": "Rappe A.K., Casewit C.J., Colwell K.S., Goddard W.A., Skiff W.M. UFF, a full periodic table force field for molecular mechanics and molecular dynamics simulations. J. Am. Chem. Soc. 1992;114:10024\u201310035. doi: 10.1021/ja00051a040.", "ArticleIdList": ["10.1021/ja00051a040"]}, {"Citation": "Hanwell M.D., Curtis D.E., Lonie D.C., Vandermeersch T., Zurek E., Hutchison G.R. Avogadro: An advanced semantic chemical editor, visualization, and analysis platform. J. Cheminform. 2012;13:17. doi: 10.1186/1758-2946-4-17.", "ArticleIdList": ["10.1186/1758-2946-4-17", "PMC3542060", "22889332"]}, {"Citation": "Agarwal R., Smith J.C. Speed vs Accuracy: Effect on Ligand Pose Accuracy of Varying Box Size and Exhaustiveness in AutoDock Vina. Mol. Inform. 2023;42:2200188. doi: 10.1002/minf.202200188.", "ArticleIdList": ["10.1002/minf.202200188", "36262028"]}, {"Citation": "Trott O., Olson A.J. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 2010;30:455\u2013461. doi: 10.1002/jcc.21334.", "ArticleIdList": ["10.1002/jcc.21334", "PMC3041641", "19499576"]}, {"Citation": "Oostenbrink C., Villa A., Mark A.E., Van Gunsteren W.F. A biomolecular force field based on the free enthalpy of hydration and solvation: The GROMOS force-field parameter sets 53A5 and 53A6. J. Comput. Chem. 2004;25:1656\u20131676. doi: 10.1002/jcc.20090.", "ArticleIdList": ["10.1002/jcc.20090", "15264259"]}, {"Citation": "Abraham M.J., Murtola T., Schulz R., P\u00e1ll S., Smith J.C., Hess B., Lindalhl E. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 2015;1:19\u201325. doi: 10.1016/j.softx.2015.06.001.", "ArticleIdList": ["10.1016/j.softx.2015.06.001"]}, {"Citation": "Berendsen H.J.C., Postma J.P.M., van Gunsteren W.F., Hermans J. Interaction models for water in relation to protein hydration. In: Pullman B., editor. Intermolecular Forces. Volume 14. Springer; Dordrecht, The Netherlands: 1981. The Jerusalem Symposia on Quantum Chemistry and Biochemistry.", "ArticleIdList": ["10.1007/978-94-015-7658-1_21"]}, {"Citation": "Kukol A. Lipid Models for United-Atom Molecular Dynamics Simulations of Proteins. J. Chem. Theor. Comput. 2009;5:615\u2013626. doi: 10.1021/ct8003468.", "ArticleIdList": ["10.1021/ct8003468", "26610227"]}, {"Citation": "Stroet M., Caron B., Visscher K.M., Geerke D.P., Malde A.K., Mark A.E. Automated Topology Builder Version 3.0: Prediction of Solvation Free Enthalpies in Water and Hexane. J. Chem. Theor. Comput. 2018;14:5834\u20135845. doi: 10.1021/acs.jctc.8b00768.", "ArticleIdList": ["10.1021/acs.jctc.8b00768", "30289710"]}, {"Citation": "Kumar S., Rosenberg J.M., Bouzida D., Swendsen R.H., Kollman P.A. THE weighted histogram analysis method for free-energy calculations on biomolecules. I. The method. J. Comput. Chem. 1992;13:1011\u20131021. doi: 10.1002/jcc.540130812.", "ArticleIdList": ["10.1002/jcc.540130812"]}, {"Citation": "Hub J.S., de Groot B.L., van der Spoel D. g_wham\u2014A Free Weighted Histogram Analysis Implementation Including Robust Error and Autocorrelation Estimates. J. Chem. Theor. Comput. 2010;12:3713\u20133720. doi: 10.1021/ct100494z.", "ArticleIdList": ["10.1021/ct100494z"]}, {"Citation": "Hess B. P-LINCS:\u2009 A Parallel Linear Constraint Solver for Molecular Simulation. J. Chem. Theor. Comput. 2008;4:116\u2013122. doi: 10.1021/ct700200b.", "ArticleIdList": ["10.1021/ct700200b", "26619985"]}, {"Citation": "Bussi G., Donadio D., Parrinello M. Canonical sampling through velocity rescaling. J. Chem. Phys. 2007;126:014101. doi: 10.1063/1.2408420.", "ArticleIdList": ["10.1063/1.2408420", "17212484"]}, {"Citation": "Parrinello M., Rahman A. Polymorphic transitions in single crystals: A new molecular dynamics method. J. Appl. Phys. 1981;52:7182\u20137190. doi: 10.1063/1.328693.", "ArticleIdList": ["10.1063/1.328693"]}, {"Citation": "Essmann U., Perera L., Berkowitz M.L., Darden T., Lee H., Pedersen L.G. A smooth particle mesh Ewald method. J. Chem. Phys. 1995;103:8577\u20138593. doi: 10.1063/1.470117.", "ArticleIdList": ["10.1063/1.470117"]}, {"Citation": " [(accessed on 13 June 2023)].  Available online:  https://www.oecd-ilibrary.org/environment/test-no-236-fish-embryo-acute-toxicity-fet-test_9789264203709-en."}, {"Citation": "Nakonieczna S., Grabarska A., Gawel K., Wr\u00f3blewska-\u0141uczka P., Czerwonka A., Stepulak A., Kukula-Koch W. Isoquinoline Alkaloids from Coptis chinensis Franch: Focus on Coptisine as a Potential Therapeutic Candidate against Gastric Cancer Cells. Int. J. Mol. Sci. 2022;23:10330. doi: 10.3390/ijms231810330.", "ArticleIdList": ["10.3390/ijms231810330", "PMC9499618", "36142236"]}, {"Citation": "Gawel K., Turski W.A., van der Ent W., Mathai B.J., Kirstein-Smardzewska K.J., Simonsen A., Esguerra C.V. Phenotypic Characterization of Larval Zebrafish (Danio rerio) with Partial Knockdown of the cacna1a Gene. Mol. Neurobiol. 2020;57:1904\u20131916. doi: 10.1007/s12035-019-01860-x.", "ArticleIdList": ["10.1007/s12035-019-01860-x", "PMC7118054", "31875924"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "7", "Day": "27"}, {"Year": "2023", "Month": "8", "Day": "24"}, {"Year": "2023", "Month": "8", "Day": "29"}, {"Year": "2023", "Month": "9", "Day": "28", "Hour": "6", "Minute": "43"}, {"Year": "2023", "Month": "9", "Day": "28", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "9", "Day": "28", "Hour": "1", "Minute": "37"}, {"Year": "2023", "Month": "8", "Day": "31"}], "PublicationStatus": "epublish", "ArticleIdList": ["37765042", "PMC10536188", "10.3390/ph16091234", "ph16091234"]}}], "PubmedBookArticle": []}